상단으로 이동
Products Applications Publications

IncuCyte™ Applications : Chemotactic Invasion


View Procotol Information프로토콜 정보 보기

What is directed cell invasion?

Chemotactic cell invasion is the directed movement of cells through an extracellular matrix in response to a chemical stimulus. It is a key component of cancer metastasis where invasive cells of the primary tumor degrade the underlying basement membrane, move toward the circulatory system and disseminate throughout the body. Metastatic potential is associated with tumor cells that have undergone epithelial-mesenchymal transition (EMT) and display a mesenchymal-like phenotype, which includes enhanced migratory capacity and invasiveness. Cell-based assays enabling real-time visualization and detailed phenotypic analysis of chemotactic cell invasion are critical to further understand the processes involved in cancer metastasis and the discovery of treatments that block metastasis.


Introducing the IncuCyte™ Chemotaxis Invasion System

A fully integrated solution enabling real-time visualization and automated analysis of chemotactic cell invasion in a 96-well format – all within your tissue culture incubator.

Investigate treatment effects on directed tumor cell invasion

Quantitatively assess metastatic potential and visualize morphological changes associated with epithelial-mesenchymal transition (EMT)

Measure chemotactic cell invasion through 3D extracellular matrix gels of your choice.

Directed invasion of HT-1080 fibrosarcoma cells through a 3D matrix of basement membrane extract (BME) toward serum. Visualized using an IncuCyte™ ClearView 96-well Cell Migration Plate. HT-1080 cells expressing a nuclear restricted red fluorescent protein (NucLight™Red Essen Bioscience 4476) were visualized and quantified in real time as they invaded through BME gel using the IncuCyte ZOOM® Live Cell Imaging System. Integrated IncuCyte™ Chemotaxis Cell Migration software enables easy quantification of cells that have moved through the membrane pores and adhere to the lower surface (indicated as blue objects).


Key advantages of the IncuCyte™ Chemotaxis Solution

Real-time visualization and fully automated analysis of tumor cell invasion

Investigate treatment effects on tumor cell invasion

Quantitatively assess metastatic potential

Highly reproducible 96-well kinetic assays suitable for screening

Investigate treatment effects on tumor cell invasion

Characterize pathways involved in directed cell invasion through pharmacological profiling and genetic manipulation

Investigate differential effects on cell migration and invasion in the same plate

Visualize morphological changes associated with epithelial-mesenchymal transition (EMT)

Image

Monitor chemotactic invasion in real time through your choice of 3D extracellular matrix gel. Time-lapse images of a nuclear red labeled HT-1080 tumor cell (black arrow) invading through a matrix of basement membrane extract toward a pore leading to serum (orange circle). The cancer cell extends into and penetrates, the matrix moving toward and through the pore. In the final image, the cancer cell has passed through the pore and has adhered to the underside of the membrane (blue circle) where it is quantified.

Investigate treatment effects on tumor cell invasion

Characterize pathways involved in directed cell invasion through pharmacological profiling and genetic manipulation

Investigate differential effects on cell migration and invasion in the same plate

Visualize morphological changes associated with epithelial-mesenchymal transition (EMT)

Image

Profile inhibitors of tumor cell invasion. IncuCyte® high-definition images of nuclear red labeled HT-1080 fibrosarcoma cells migrating across a 2D substrate and invading through a 3D basement membrane extract (BME) biomatrix in response to a serum gradient – note the differential morphology and invasive filopodia-like projections that extend into the ECM. Time course plots reveal that cell invasion through the BME matrix is slower than migration and that invasion, but not migration, is inhibited by the matrix metalloproteinase inhibitor, GM6001 in a concentration dependent manner.

Quantitatively assess metastatic potential

Cross compare the invasive capacity of cell types in a single plate (e.g. isogenic pairs, tumor biopsies)

Image

Quantify metastatic potential. Comparison of the migration and invasion time-course profiles for a highly invasive (HT-1080 fibrosarcoma) and weakly invasive (NIH-3T3 fibroblast) cell type in the presence of increasing 3D gel density (basement membrane extract). Note that the NIH-3T3 cells are effectively unable to invade through the ECM, but do migrate in the absence of the 3D biomatrix. NIH-3T3 cells show less metastatic potential than HT-1080 cells.

Highly reproducible 96-well kinetic assays suitable for screening

Measure chemotactic cell invasion in up to six 96-well plates at once (576 wells of data at every time point)

Set up and walk away – fully automated image based quantification

Compatible with standard automation and liquid dispensing devices

Image

Robust 96-well assays. Representative 96-well microplate graphs showing HT-1080 invasion through a 3D basement membrane extract biomatrix towards serial dilutions of serum to illustrate inter-plate reproducibility. Z’ values ranged from 0.7 to 0.8 for four replicate plates over three days. Corresponding concentration-dependent response curves to FBS provided reproducible measurements of the pro-invasive effects of serum (EC50 value range 1.5% to 3.4%) within and between days.